Hot Life Science Investor Mandate 2: US Based VC Seeking Seed and Series A Therapeutic Opportunities

28 Aug

A US based venture capital fund is looking to make seed and series A stage investments into life science companies with investments ranging anywhere from $500,000 initially to $25 million over the lifetime of the investment. The firm is actively reviewing opportunities throughout the United States and could make as many as 6 investments over the next year.

Within the life science space the firm is primarily focused on therapeutics. Within therapeutics the firm is opportunistic in terms of technology type and is open to both single asset and platform technology companies. The firm is most interest in companies targeting white space indications and is generally less interest in highly crowded areas including diabetes, Alzheimer’s and solid tumors. The firm is primarily interest in pre-clinical companies however they are open to later stage technologies as well pending it is a series A round or earlier.

The firm is looking for companies with experienced management teams and is very open to working with incomplete management teams. The firm looks to act as an active value adding investor and requires a board seat following investment.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: